Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Evaluation of anti-inflammatory effect of Varanadi Kashayam (decoction) in THP-1-derived macrophages.

Chinchu JU, Mohan MC, Devi SJR, Kumar BP.

Ayu. 2018 Oct-Dec;39(4):243-249. doi: 10.4103/ayu.AYU_53_18.

2.

Field level evaluation of rice introgression lines for heat tolerance and validation of markers linked to spikelet fertility.

Prasanth VV, Basava KR, Babu MS, V G N VT, Devi SJ, Mangrauthia SK, Voleti SR, Sarla N.

Physiol Mol Biol Plants. 2016 Apr;22(2):179-92. doi: 10.1007/s12298-016-0350-6. Epub 2016 Apr 15.

3.

Nucleotide variation and identification of novel blast resistance alleles of Pib by allele mining strategy.

Ramkumar G, Madhav MS, Devi SJ, Prasad MS, Babu VR.

Physiol Mol Biol Plants. 2015 Apr;21(2):301-4. doi: 10.1007/s12298-015-0284-4. Epub 2015 Mar 11.

4.

Identification of abiotic stress miRNA transcription factor binding motifs (TFBMs) in rice.

Devi SJ, Madhav MS, Kumar GR, Goel AK, Umakanth B, Jahnavi B, Viraktamath BC.

Gene. 2013 Nov 15;531(1):15-22. doi: 10.1016/j.gene.2013.08.060. Epub 2013 Aug 28.

PMID:
23994683
5.

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Maslanka SE, Gheesling LL, Libutti DE, Donaldson KB, Harakeh HS, Dykes JK, Arhin FF, Devi SJ, Frasch CE, Huang JC, Kriz-Kuzemenska P, Lemmon RD, Lorange M, Peeters CC, Quataert S, Tai JY, Carlone GM.

Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67.

7.

Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.

Devi SJ, Zollinger WD, Snoy PJ, Tai JY, Costantini P, Norelli F, Rappuoli R, Frasch CE.

Infect Immun. 1997 Mar;65(3):1045-52.

8.
9.

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model.

Devi SJ.

Vaccine. 1996 Jun;14(9):841-4. Review. Erratum in: Vaccine 1996 Sep;14(13):1298.

PMID:
8843625
11.

The Devi case and more.

Devi SJ.

Science. 1995 Aug 25;269(5227):1030. No abstract available.

PMID:
7652537
12.
14.

Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD.

J Infect Dis. 1992 Jun;165(6):1086-93.

PMID:
1583327
15.
16.

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Devi SJ, Schneerson R, Egan W, Ulrich TJ, Bryla D, Robbins JB, Bennett JE.

Infect Immun. 1991 Oct;59(10):3700-7.

18.
19.

Serological evaluation of brucellosis: importance of species in antigen preparation.

Devi SJ, Polt SS, Boctor FN, Peter JB.

J Infect Dis. 1987 Oct;156(4):658-61. No abstract available.

PMID:
3114390

Supplemental Content

Support Center